The lean body mass to visceral fat mass ratio is negatively associated with cardiometabolic disorders: a cross-sectional study
- PMID: 39870802
- PMCID: PMC11772826
- DOI: 10.1038/s41598-025-88167-1
The lean body mass to visceral fat mass ratio is negatively associated with cardiometabolic disorders: a cross-sectional study
Abstract
The literature has documented conflicting and inconsistent associations between muscle-to-fat ratios and metabolic diseases. Additionally, different adipose tissues can have contrasting effects, with visceral adipose tissue being identified as particularly harmful. This study aimed to explore the relationship between the ratio of the lean mass index (LMI) to the visceral fat mass index (VFMI) and cardiometabolic disorders, including dyslipidemia, hypertension, and diabetes, as previous research on this topic is lacking. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in the United States and included 10,867 individuals. Logistic regression was employed to explore the association between LMI/VFMI and cardiometabolic disorders. Generalized additive models were utilized to examine the nonlinear relationships between variables. Data analysis revealed a consistent inverse association between ln(LMI/VFMI) and dyslipidemia, hypertension, and diabetes. Each 2.7-fold increase in LMI/VFMI (one unit of ln[LMI/VFMI]) was associated with lower odds ratios (ORs) for these conditions. In men, the ORs were 0.21 (95% CI 0.17-0.25) for dyslipidemia, 0.37 (95% CI 0.30-0.45) for hypertension, and 0.16 (95% CI 0.10-0.23) for diabetes. Similarly, in women, the ORs were 0.22 (95% CI 0.19-0.26), 0.51 (95% CI 0.42-0.61), and 0.19 (95% CI 0.13-0.27). Quartile analysis showed that participants in the highest quartile (Q4) had significantly lower ORs compared to those in the lowest quartile (Q1). In men, Q4 ORs were 0.18 (95% CI 0.14-0.23) for dyslipidemia, 0.30 (95% CI 0.23-0.39) for hypertension, and 0.11 (95% CI 0.06-0.20) for diabetes. In women, Q4 ORs were 0.12 (95% CI 0.10-0.15), 0.39 (95% CI 0.29-0.52), and 0.12 (95% CI 0.06-0.25), respectively. Dyslipidemia and diabetes demonstrated nonlinear patterns, while a linear association was found for hypertension. Subgroup analyses across various characteristics confirmed these findings with no substantial directional changes. Maintaining an appropriate ratio of LMI to VFMI may be associated with favorable metabolic health.
Keywords: Cardiometabolic disorders; Diabetes; Dyslipidemia; Hypertension; Lean body mass; Visceral fat mass.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Association of serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) with risk of myocardial infarction among individuals with diabetes: a cross-sectional analysis using data from NHANES 2005-2020.Eur J Med Res. 2025 Jul 2;30(1):554. doi: 10.1186/s40001-025-02845-4. Eur J Med Res. 2025. PMID: 40605038 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
The association between body roundness index and risk of osteoporosis in patients with type 2 diabetes mellitus: A cross-sectional study based on NHANES database.J Orthop Surg (Hong Kong). 2025 May-Aug;33(2):10225536251356804. doi: 10.1177/10225536251356804. Epub 2025 Jul 1. J Orthop Surg (Hong Kong). 2025. PMID: 40591954
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass.Front Endocrinol (Lausanne). 2025 Apr 4;16:1539550. doi: 10.3389/fendo.2025.1539550. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40255497 Free PMC article.
-
Muscle quality index and hyperuricemia: adipose tissue as a mediator.Front Endocrinol (Lausanne). 2025 May 27;16:1562837. doi: 10.3389/fendo.2025.1562837. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40496566 Free PMC article.
References
-
- Miranda, J. J. et al. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat. Med.25, 1667–1679 (2019). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical